Phaos Technology Holdings (Cayman) (POAS) Other Non-Current Liabilities (2025)
Phaos Technology Holdings (Cayman) (POAS) posted Other Non-Current Liabilities of $1.9 million for Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Other Non-Current Liabilities (2025) Analysis & Trends
Phaos Technology Holdings (Cayman)'s Other Non-Current Liabilities history runs 1 years deep, the most recent figure standing at $1.9 million for Q2 2025.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $1.9 million in Q2 2025, while the trailing twelve-month figure through Apr 2025 was $1.9 million (changed N/A YoY) and the FY2025 annual result came in at $2.0 million, changed N/A from the prior year.
- Other Non-Current Liabilities was $1.9 million for Q2 2025 at Phaos Technology Holdings (Cayman).
- Across five years, Other Non-Current Liabilities topped out at $1.9 million in Q2 2025 and bottomed at $1.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.08 Bn | 175.79 Bn | 6.27 Bn |
| 2 | Stryker | 128.71 Bn | 125.83 Bn | 3.81 Bn |
| 3 | Medtronic | 108.79 Bn | 99.57 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.41 Bn | 66.96 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 7 | Dexcom | 28.34 Bn | 27.22 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.87 Bn | 26.29 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 6.17 Mn | 6.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 1.95 Mn |